HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $782,401 | -85.5% | 9,455 | -88.3% | 0.02% | -70.6% |
| Q2 2021 | $5,394,000 | +330.5% | 80,935 | +617.1% | 0.05% | +325.0% |
| Q1 2021 | $1,253,000 | +39.8% | 11,287 | +12.9% | 0.01% | -53.8% |
| Q2 2020 | $896,000 | +326.7% | 10,000 | +374.6% | 0.03% | +420.0% |
| Q1 2020 | $210,000 | -83.1% | 2,107 | -80.6% | 0.01% | -80.8% |
| Q4 2019 | $1,246,000 | +41.1% | 10,844 | +54.8% | 0.03% | +18.2% |
| Q3 2019 | $883,000 | -19.8% | 7,003 | -23.5% | 0.02% | 0.0% |
| Q2 2019 | $1,101,000 | -63.1% | 9,150 | -73.1% | 0.02% | -71.4% |
| Q1 2019 | $2,980,000 | +960.5% | 34,062 | +443.3% | 0.08% | +1440.0% |
| Q3 2017 | $281,000 | -77.9% | 6,270 | -80.6% | 0.01% | -75.0% |
| Q2 2017 | $1,274,000 | +278.0% | 32,254 | +246.6% | 0.02% | +300.0% |
| Q3 2016 | $337,000 | – | 9,307 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |